Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-24

Clinical Trial Update: Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial updating the use of human umbilical cord mesenchymal stem cells for rheumatoid arthritis. The study status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Shenzhen Hornetcorn Bio-technology Company, LTD | Conditions: Rheumatoid Arthritis | Phase 1 | Status: UNKNOWN